跳至主要内容
临床试验/NCT03609073
NCT03609073终止不适用

A Prospective Study to Evaluate the Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) as an Aid for Diverticulum Treatment

Erasme University Hospital2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2018年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
4
试验地点
2
主要终点
Incidence of all Adverse Device Effects

研究概览

简要总结

Esophageal diverticulum is a rare disease. Majority comes form the pharyngo-esophageal junction (70 % Zenker's Diverticulum), 10% are mediothoracic and 20% epiphrenic. Zenker's diverticulum is well treated with endoscopy (efficacy around 80%, complications around 5%) (1). For medio or epihrenic diverticulum, the classic treatment is surgery (diverticulectomy with or without anti-reflux surgery) but is associated with 33% morbidity and 9% mortality (2). Recently another technique involving magnet was described (3). Five patients were treated with success.

Considering the surgical risk, other techniques need to be evaluated. Using the Endomina device, sutures can be apposed between the foot of the diverticulum and the esophageal lumen. If necessary the bridge between the diverticulum and the esophagus can be cut with needle knife as described in Zenker's diverticulum treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic medio or epiphrenic diverticulum.
  • Age between 18-80 years;
  • Must be able to comply with all study requirements for the duration of the study as outlined in the protocol. This includes complying with the visit schedule as well as study specific procedures such as: clinical assessment, endoscopy, radiography, as well as laboratory investigations;
  • Must be able to understand and be willing to provide written informed consent;
  • Must live within 75 km of the treatment site;

排除标准

  • Achalasia and any other esophageal motility disorders.
  • Severe esophagitis
  • Gastro-duodenal ulcer
  • Severe renal, hepatic, pulmonary disease or cancer;
  • GI stenosis or obstruction;
  • Pregnancy, breastfeeding or willing to become pregnant in the coming 18 months;
  • Anticoagulant therapy;
  • Currently participating in other study

结局指标

主要结局

Incidence of all Adverse Device Effects

时间窗: one year from procedure

Safety will be characterized by the incidence of all Adverse Device Effects

次要结局

  • Dysphagia(one year from procedure)

研究者

发起方
Erasme University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Endomina Diverticulum | 临床试验